Manufacturer copay assistance · Fylnetra (Q5130) · Amneal Biosciences
Eligible commercially… · Covers Fylnetra drug cost only — administration billed separately
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
No foundation fund in our catalog currently matches Fylnetra — check the full fund board.
Yes — Amneal PATHways Co-Pay Assistance (Fylnetra) from Amneal Biosciences. Eligible commercially insured patients may pay as little as $0 per treatment through Amneal PATHways. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
Eligible commercially insured patients may pay as little as $0 per treatment through Amneal PATHways Maximum benefit: not published. Covers Fylnetra drug cost only — administration billed separately
Accepted insurance: commercial. Not eligible: medicare, medicaid, government.